DENVER, Sept. 02, 2016 -- Global cannabidiol (CBD) manufacturer Elixinol is the first company in the world to receive the seal of approval for its CBD products from Realm of Caring, a global non-profit providing support services, resources and research for cannabinoid users.
|
|||
The Realm of Caring seal of approval, the first of its kind in the cannabis industry is awarded to companies after a lengthy independent review of manufacturing and sourcing practices. The seal of approval provides those using CBD with a way to identify the highest-quality CBD in the marketplace.
The circular seal will be included on all Elixinol products beginning October 1, 2016 and customers will see the Realm of Caring seal of approval online at Elixinol.com immediately.
“We’re honored to have our organic, whole-plant CBD be the first awarded this prestigious recognition of high quality CBD by Realm of Caring, an industry leader and educator,” said Paul Benhaim, Elixinol co-founder. “We know it’s important for those using CBD to be able to trust the product. To see our efforts, which are setting the global standard for the CBD industry, recognized is truly rewarding.”
Elixinol is also partnering with Realm of Caring clients on important CBD research at Johns Hopkins University, including those affected by numerous disorders and diseases including Cancer, Multiple Sclerosis, Chronic Pain, HIV/AIDS, Epilepsy, and Parkinson's to name a few.
“Education and research is an important core mission of Elixinol. The more people understand about CBD, the more they can make informed choices, and we want to help them get the best information and the highest-quality product, so this seal of approval is truly a reflection of our expectations of ourselves, our process and the future of CBD,” said Benhaim.
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD manufacturers in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in distribution, consulting and hemp education, Elixinol distributes CBD products in the United States, Japan, Puerto Rico and the UK. Elixinol and its global partners, including Elixinol Japan, recently introduced hemp oil Liposomes, with superior absorption and real fruit flavor, and the X-pen, the most precise CBD oil delivery system. More information available at Elixinol.com.
About The Realm of Caring Foundation:
The Realm of Caring is a 501(c)3 non-profit that provides support services and resources to those using cannabinoid products. The Realm is primarily lead by parent professionals whose children have benefitted from this therapy. The Realm of Caring currently serves nearly 28,000 members. For more information about the Realm of Caring’s programs and services, visit www.theroc.us.
For more information, photos or interview Chris Husong [email protected]


Anta Sports Expands Global Footprint With Strategic Puma Stake
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



